Related Experiment Video
Updated: Mar 24, 2026

08:43
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
11.0K
Automated screening for small organic ligands using DNA-encoded chemical libraries
Willy Decurtins1, Moreno Wichert1, Raphael M Franzini1
1Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH Zurich), Zurich, Switzerland.
Nature Protocols
|March 18, 2016
Summary
DNA-encoded chemical libraries (DECLs) enable rapid identification of small organic ligands. This protocol details automated screening, DNA sequencing, and data analysis to discover binders for biological targets within 10 days.
Area of Science:
- Chemical Biology
- Drug Discovery
- Molecular Biology
Background:
- DNA-encoded chemical libraries (DECLs) link organic compounds to unique DNA barcodes for identification.
- DECLs allow for the screening of vast chemical spaces against biological targets.
- Efficient methods are needed to identify specific binding molecules within these large libraries.
Purpose of the Study:
- To describe a protocol for screening DNA-encoded chemical libraries (DECLs).
- To enable the identification of small organic ligands that bind to target proteins.
- To establish a rapid and efficient method for affinity selection and binder identification.
Main Methods:
- Automated affinity selection to isolate binding library members.
- Polymerase chain reaction (PCR) amplification of DNA barcodes from isolated binders.
- High-throughput DNA sequencing and computational analysis (C++ and MATLAB) of sequencing data.
Main Results:
- Successful isolation of binding molecules from a DECL.
- Generation of selection fingerprints to differentiate binders from non-binders.
- Identification of small organic ligands to biological targets within a 10-day timeframe.
Conclusions:
- The described protocol provides an efficient method for identifying small molecule binders using DECLs.
- Automated screening and DNA sequencing significantly accelerate the drug discovery process.
- This approach facilitates the discovery of novel ligands for various biological targets.

